Literature DB >> 20412398

Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.

Adriele Ferreira Gouvêa1, Pablo Agustin Vargas, Ricardo D Coletta, Jacks Jorge, Márcio Ajudarte Lopes.   

Abstract

BACKGROUND: Proliferative verrucous leukoplakia (PVL) is a distinct and aggressive type of oral leukoplakia which affects elderly women without risk behavior and presents high rates of malignant transformation. The objective of the present study was to evaluate the clinicopathological characteristics and the distribution of cell proliferation markers, aiming to elucidate the distinct biological behavior of the PVL.
METHODS: Clinical and microscopical features of 12 patients with PVL were reviewed. Immunohistochemical analysis for p53, Ki-67, Mcm-2 and Mcm-5 were performed and the data were correlated.
RESULTS: All patients were women, above 50 years of age, 91.7% were non-smoker and 100% were non-habitual drinker. Alveolar ridge (66.6%), tongue (50%) and buccal mucosa (41.6%) were the most affected sites. Four patients developed squamous cell carcinoma (SCC). The immunohistochemical findings showed higher positivity for p53, Ki-67, Mcm-2 and Mcm-5 in SCCs. However, some patients with mild or moderate dysplasia, specially the patients who developed SCC, presented high expression of Mcm-2 and Mcm-5.
CONCLUSIONS: High immunoexpression of Mcm-2 and Mcm-5 in mild and moderate dysplasia could be helpful to predict the malignant transformation of PVL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412398     DOI: 10.1111/j.1600-0714.2010.00889.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  Proliferative verrucous leukoplakia may initially mimic lichenoid reactions.

Authors:  Marcio Ajudarte Lopes; Patricia Feio; Alan Roger Santos-Silva; Pablo Agustin Vargas
Journal:  World J Clin Cases       Date:  2015-10-16       Impact factor: 1.337

2.  Immunohistochemical expression and evaluation of cyclin D1 and minichromosome maintenance 2 in oral squamous cell carcinoma and verrucous carcinoma.

Authors:  T R Menaka; S Shamala Ravikumar; K Dhivya; N Thilagavathi; J Dinakaran; Vinoth Kalaichelvan
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

3.  Low expression of angiotensinogen and dipeptidyl peptidase 1 in saliva of patients with proliferative verrucous leukoplakia.

Authors:  Isadora Luana Flores; Alan Roger Santos-Silva; Ricardo Della Coletta; Adriana Franco Paes Leme; Marcio Ajudarte Lopes
Journal:  World J Clin Cases       Date:  2016-11-16       Impact factor: 1.337

4.  PITX1 is a reliable biomarker for predicting prognosis in patients with oral epithelial dysplasia.

Authors:  Motoki Nakabayashi; Mitsuhiko Osaki; Isamu Kodani; Futoshi Okada; Kazuo Ryoke; Mitsuo Oshimura; Hisao Ito; Hiroyuki Kugoh
Journal:  Oncol Lett       Date:  2013-12-24       Impact factor: 2.967

5.  MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma.

Authors:  Sarocha Vivatvakin; Thanaporn Ratchataswan; Thiratest Leesutipornchai; Komkrit Ruangritchankul; Somboon Keelawat; Patnarin Mahattanasakul; Saknan Bongsebandhu-Phubhakdi
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

Review 6.  Proliferative verrucous leukoplakia: diagnosis, management and current advances.

Authors:  Diogo Lenzi Capella; Jussara Maria Gonçalves; Adelino António Artur Abrantes; Liliane Janete Grando; Filipe Ivan Daniel
Journal:  Braz J Otorhinolaryngol       Date:  2017-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.